BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Altorjay I, Veréb Z, Serfozo Z, Bacskai I, Bátori R, Erdodi F, Udvardy M, Sipka S, Lányi Á, Rajnavölgyi É, Palatka K. Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells. Int J Immunopathol Pharmacol 2011;24:323-35. [PMID: 21658307 DOI: 10.1177/039463201102400206] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Triantafyllou C, Nikolaou M, Ikonomidis I, Bamias G, Papaconstantinou I. Endothelial and Cardiac Dysfunction in Inflammatory Bowel Diseases: Does Treatment Modify the Inflammatory Load on Arterial and Cardiac Structure and Function? Curr Vasc Pharmacol 2020;18:27-37. [PMID: 30488796 DOI: 10.2174/1570161117666181129095941] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ferreira-Duarte M, Sousa JB, Diniz C, Sousa T, Duarte-Araújo M, Morato M. Experimental and Clinical Evidence of Endothelial Dysfunction in Inflammatory Bowel Disease. Curr Pharm Des 2020;26:3733-47. [PMID: 32611296 DOI: 10.2174/1381612826666200701212414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Li MY, Li MX, Xu N, Li ZH, Zhang YM, Gan YX, Luo HJ, Zhou CL, Liu YH, Su ZR, Huang XQ, Zheng XB. Effects of Huangqin Decoction on ulcerative colitis by targeting estrogen receptor alpha and ameliorating endothelial dysfunction based on system pharmacology. J Ethnopharmacol 2021;271:113886. [PMID: 33524513 DOI: 10.1016/j.jep.2021.113886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tetè S, Tripodi D, Rosati M, Conti F, Maccauro G, Saggini A, Salini V, Cianchetti E, Caraffa A, Antinolfi P, Toniato E, Castellani ML, Pandolfi F, Frydas S, Conti P, Theoharides TC. Endothelial cells, cholesterol, cytokines, and aging. Int J Immunopathol Pharmacol 2012;25:355-63. [PMID: 22697067 DOI: 10.1177/039463201202500205] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
5 Nicoletti M, Neri G, Maccauro G, Tripodi D, Varvara G, Saggini A, Potalivo G, Castellani M, Fulcheri M, Rosati M, Toniato E, Caraffa A, Antinolfi P, Cerulli G, Pandolfi F, Galzio R, Conti P, Theoharides T. Impact and Neuropeptide Substance Pan Inflammatory Compound on Arachidonic Acid Compound Generation. Int J Immunopathol Pharmacol 2012;25:849-57. [DOI: 10.1177/039463201202500403] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
6 Owlia MB, Mehrpoor G. Behcet's Disease: New Concepts in Cardiovascular Involvements and Future Direction for Treatment. ISRN Pharmacol 2012;2012:760484. [PMID: 22530146 DOI: 10.5402/2012/760484] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
7 Filho AG, Kinote A, Pereira DJ, Rennó A, dos Santos RC, Ferreira-melo SE, Velloso LA, Bordin S, Anhê GF, Junior HM. Infliximab prevents increased systolic blood pressure and upregulates the AKT/eNOS pathway in the aorta of spontaneously hypertensive rats. European Journal of Pharmacology 2013;700:201-9. [DOI: 10.1016/j.ejphar.2012.11.059] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
8 Triantafyllou C, Nikolaou M, Ikonomidis I, Bamias G, Kouretas D, Andreadou I, Tsoumani M, Thymis J, Papaconstantinou I. Effects of Anti-Inflammatory Treatment and Surgical Intervention on Endothelial Glycocalyx, Peripheral and Coronary Microcirculatory Function and Myocardial Deformation in Inflammatory Bowel Disease Patients: A Two-Arms Two-Stage Clinical Trial. Diagnostics (Basel) 2021;11:993. [PMID: 34070768 DOI: 10.3390/diagnostics11060993] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhang L, Ocansey DKW, Liu L, Olovo CV, Zhang X, Qian H, Xu W, Mao F. Implications of lymphatic alterations in the pathogenesis and treatment of inflammatory bowel disease. Biomed Pharmacother 2021;140:111752. [PMID: 34044275 DOI: 10.1016/j.biopha.2021.111752] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Cantatore FP, Maruotti N, Corrado A, Ribatti D. Anti-angiogenic effects of biotechnological therapies in rheumatic diseases. Biologics 2017;11:123-8. [PMID: 29276377 DOI: 10.2147/BTT.S143674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
11 Maccauro G, Tetè S, Saggini A, Tripodi D, Castellani M, Conti F, Cianchetti E, Conti C, Rosati M, Toniato E, Fulcheri M, Salini V, Caraffa A, Antinolfi P, Frydas S, Torello M, Neri G, Pandolfi F, Conti P, Theoharides T. Induction of CCL2 (MCP-1) BY IL-33 in Human Umbelical Cord Blood Mast Cells. Eur J Inflamm 2017;10:217-26. [DOI: 10.1177/1721727x1201000207] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 Nicoletti M, Maccauro G, Tripodi D, Saggini A, Potalivo G, Castellani M, Conti F, Rosati M, Tomato E, Caraffa A, Antinolfi P, Conti P, Theoharides T. Impact of IL-33 on PGD2 Generation by Activated Human Cord Blood-Derived Mast Cell: Lack of Effect on Tryptase Release. Eur J Inflamm 2012;10:473-82. [DOI: 10.1177/1721727x1201000323] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]